Li P, Sun H, Zhou P, Ma C, Hu G, Jiang H
Acta Pharmacol Sin. 2012; 33(6):728-36.
PMID: 22609836
PMC: 4085657.
DOI: 10.1038/aps.2012.41.
Srivatsa U, Wadhani N, Singh B
Curr Cardiol Rep. 2002; 4(5):401-10.
PMID: 12169237
DOI: 10.1007/s11886-002-0040-6.
Lau W, Newman D, Dorian P
Drugs. 2001; 60(6):1315-28.
PMID: 11152014
DOI: 10.2165/00003495-200060060-00006.
Hancox J, Patel K, Jones J
Heart. 2000; 84(1):14-24.
PMID: 10862579
PMC: 1729402.
DOI: 10.1136/heart.84.1.14.
Marshall R, Muir A, Winslow E
Br J Pharmacol. 1981; 74(2):381-8.
PMID: 7317687
PMC: 2071715.
DOI: 10.1111/j.1476-5381.1981.tb09982.x.
Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.
Hellestrand K, Bexton R, Nathan A, Spurrell R, Camm A
Br Heart J. 1982; 48(2):140-8.
PMID: 7093083
PMC: 481218.
DOI: 10.1136/hrt.48.2.140.
Mianserin, maprotiline and intracardiac conduction.
Edwards J, Goldie A
Br J Clin Pharmacol. 1983; 15 Suppl 2:249S-254S.
PMID: 6824556
PMC: 1427885.
DOI: 10.1111/j.1365-2125.1983.tb05872.x.
The effect of a new antiarrhythmic agent, flecainide acetate, on systolic time intervals.
Muhiddin K, Shaw E, Blackett A, Patel L, Turner P
Eur J Clin Pharmacol. 1983; 25(1):13-8.
PMID: 6617715
DOI: 10.1007/BF00544007.
Electromechanical effects of bepridil on rabbit isolated hearts.
Anno T, Furuta T, Itoh M, Kodama I, TOYAMA J, Yamada K
Br J Pharmacol. 1984; 81(1):41-7.
PMID: 6608388
PMC: 1986954.
DOI: 10.1111/j.1476-5381.1984.tb10741.x.
Antidepressant overdosage.
Crome P
Drugs. 1982; 23(6):431-61.
PMID: 6213400
DOI: 10.2165/00003495-198223060-00002.
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Schmitz W
Klin Wochenschr. 1980; 58(18):907-18.
PMID: 6110804
DOI: 10.1007/BF01477048.
The proarrhythmic effects of flecainide.
Nathan A, Hellestrand K, Bexton R, Spurrell R, Camm A
Drugs. 1985; 29 Suppl 4:45-53.
PMID: 4006779
DOI: 10.2165/00003495-198500294-00010.
Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.
Muhiddin K, Turner P
Postgrad Med J. 1985; 61(718):665-77.
PMID: 3898053
PMC: 2418373.
DOI: 10.1136/pgmj.61.718.665.
Syncope and sudden unexpected death attributed to carbamazepine in a 20-year-old epileptic.
Stone S, Lange L
J Neurol Neurosurg Psychiatry. 1986; 49(12):1460-1.
PMID: 3806129
PMC: 1029141.
DOI: 10.1136/jnnp.49.12.1460.
Differing electrophysiological effects of class IA, IB and IC antiarrhythmic drugs on guinea-pig sinoatrial node.
Campbell T
Br J Pharmacol. 1987; 91(2):395-401.
PMID: 3607364
PMC: 1853523.
DOI: 10.1111/j.1476-5381.1987.tb10294.x.
Poisoning due to tricyclic antidepressant overdosage. Clinical presentation and treatment.
Crome P
Med Toxicol. 1986; 1(4):261-85.
PMID: 3537621
DOI: 10.1007/BF03259843.
Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.
Brogden R, Todd P
Drugs. 1987; 34(2):151-87.
PMID: 3304965
DOI: 10.2165/00003495-198734020-00001.
Stopping and restarting medications in the perioperative period.
Cygan R, Waitzkin H
J Gen Intern Med. 1987; 2(4):270-83.
PMID: 3302147
DOI: 10.1007/BF02596452.
Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
Tanabe T
Cardiovasc Drugs Ther. 1991; 5 Suppl 4:827-34.
PMID: 1931759
DOI: 10.1007/BF00120831.
Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.
Nattel S
Drugs. 1991; 41(5):672-701.
PMID: 1712704
DOI: 10.2165/00003495-199141050-00002.
